Seres Therapeutics Q2 2018 Earnings Report

Total Revenue
$4.61M
Previous year: $3.01M
+53.0%
EPS
-$0.68
Previous year: -$0.69
-1.4%

Seres Therapeutics

Seres Therapeutics